Plasma and tissue resveratrol concentrations and pharmacological activity
- PMID: 9825229
Plasma and tissue resveratrol concentrations and pharmacological activity
Abstract
In this study a comparison was made between results obtained from resveratrol dosages which have been shown to be pharmacologically active, in vitro and in vivo, and the results of plasma and tissue concentrations obtained after a single administration or after prolonged administration of red wine with a known resveratrol content. The dosages used by different investigators in the tests are very different and, in general, rather high in relation to the concentrations which are found in wine or grapes. The results of our tests on platelet aggregation confirm that even with modest dosages of resveratrol, a pharmacological effect can be observed, and that these dosages can be compatible with the resveratrol concentrations obtained after oral administration. The data obtained from these tests on animals can lead to the conclusion that even an average drinker of wine can, particularly in the long term, absorb a sufficient quantity of resveratrol to explain the beneficial effect of red wine on health, which has been observed in epidemiological studies carried out in populations whose daily diet includes the drinking of wine.
Similar articles
-
Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats.Int J Tissue React. 1996;18(2-3):67-71. Int J Tissue React. 1996. PMID: 9063768
-
Antiplatelet activity of synthetic and natural resveratrol in red wine.Int J Tissue React. 1995;17(1):1-3. Int J Tissue React. 1995. PMID: 7499059
-
Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats.Int J Clin Pharmacol Res. 1996;16(4-5):77-81. Int J Clin Pharmacol Res. 1996. PMID: 9172004
-
The red wine hypothesis: from concepts to protective signalling molecules.Eur Heart J. 2007 Jul;28(14):1683-93. doi: 10.1093/eurheartj/ehm149. Epub 2007 Jun 7. Eur Heart J. 2007. PMID: 17561496 Review.
-
Grapes, wines, resveratrol, and heart health.J Cardiovasc Pharmacol. 2009 Dec;54(6):468-76. doi: 10.1097/FJC.0b013e3181bfaff3. J Cardiovasc Pharmacol. 2009. PMID: 19770673 Review.
Cited by
-
Specific Conditions for Resveratrol Neuroprotection against Ethanol-Induced Toxicity.J Toxicol. 2012;2012:973134. doi: 10.1155/2012/973134. Epub 2012 Jun 17. J Toxicol. 2012. PMID: 22778731 Free PMC article.
-
Benefits of dietary polyphenols in Alzheimer's disease.Front Aging Neurosci. 2022 Dec 13;14:1019942. doi: 10.3389/fnagi.2022.1019942. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36583187 Free PMC article. Review.
-
Resveratrol-induced gene expression profiles in human prostate cancer cells.Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):596-604. doi: 10.1158/1055-9965.EPI-04-0398. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767336 Free PMC article.
-
Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.AAPS PharmSciTech. 2011 Mar;12(1):279-86. doi: 10.1208/s12249-011-9584-3. Epub 2011 Jan 15. AAPS PharmSciTech. 2011. PMID: 21240574 Free PMC article.
-
The Mediterranean Diet as a Source of Bioactive Molecules with Cannabinomimetic Activity in Prevention and Therapy Strategy.Nutrients. 2022 Jan 21;14(3):468. doi: 10.3390/nu14030468. Nutrients. 2022. PMID: 35276827 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical